Your Location：
Home >
Browse articles >
Modified Linggui Zhugan Decoction (加味苓桂术甘汤) Ameliorates Glycolipid Metabolism and Inflammation via PI3K-Akt/mTOR-S6K1/AMPK-PGC-1 α Signaling Pathways in Obese Type 2 Diabetic Rats
Updated：2021-09-24
|

    • Modified Linggui Zhugan Decoction (加味苓桂术甘汤) Ameliorates Glycolipid Metabolism and Inflammation via PI3K-Akt/mTOR-S6K1/AMPK-PGC-1 α Signaling Pathways in Obese Type 2 Diabetic Rats

    • Chinese Journal of Integrative Medicine   Pages: 1-8

    Scan for full text

  • Jia-pan Sun, Lin Shi, Fang Wang, et al. Modified Linggui Zhugan Decoction (加味苓桂术甘汤) Ameliorates Glycolipid Metabolism and Inflammation via PI3K-Akt/mTOR-S6K1/AMPK-PGC-1 α Signaling Pathways in Obese Type 2 Diabetic Rats. [J/OL]. 1-8(0) DOI：

  •  
  •  
FULL TEXT LINK
More>

0

Views

0

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Schisandrin B Protects against Ischemic Brain Damage by Regulating PI3K/AKT Signaling in Rats
Polypeptide from Moschus Suppresses Lipopolysaccharide-Induced Inflammation by Inhibiting NF-κ B-ROS/NLRP3 Pathway

Related Author

No data

Related Institution

Department of Neurology, The First Hospital of Quanzhou Affiliated to Fujian Medical University, Quanzhou, Fujian Province, China;Department of Neurosurgery, Fujian Medical University Union Hospital, Fuzhou, China
Department of Pharmacology, Southwest Medical University, Luzhou, Sichuan Province, China;Sichuan Institute for Translational Chinese Medicine, Translational Chinese Medicine Key Laboratory of Sichuan Province, Sichuan Academy of Chinese Medicine Sciences, Chengdu, China;Hunan Provincial Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, College of Pharmacy, Changsha Medical University, Changsha, China;Sichuan Fengchun Pharmaceutical Co., Ltd., Deyang, Sichuan Province, China;Sichuan Ant Recommendation Biotechnology Co., Ltd., Chengdu, China
0